FDA Adverse Event Malfunction Summary report: N

VIDAS HCG

MDR report key: 10907491 · Received November 26, 2020

Report

Report Number
8020790-2020-00127
Event Type
Malfunction
Date Received
November 26, 2020
Report Date
November 25, 2020
Manufacturer
BIOMERIEUX SA
Product Code
JLW
PMA / PMN Number
K141133
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Description of Event or Problem · 1

A CUSTOMER IN (B)(6) NOTIFIED BIOMÉRIEUX THAT THEY OBSERVED OUT OF RANGE HIGH RESULTS WHEN USING VIDAS® HCG 60 TESTS (REF. 30405, LOT 1008107910), IN THE CONTEXT OF AN EXTERNAL QUALITY CONTROL. AS THIS WAS AN EXTERNAL QUALITY CONTROL SAMPLE, THERE IS NO PATIENT INVOLVED. THE CUSTOMER OBTAINED THE FOLLOWING RESULTS WHEN TESTING THE LIQUICHEK IMMUNOASSAY PLUS CONTROL BIO-RAD, LEVEL 1 WITH VIDAS HCG 60 TESTS, LOT 1008107910: ON (B)(6) 2020: 5.39 MUI/ML. ON (B)(6) 2020: 5.55 MUI/ML, 6.29 MUI/ML, 6.07 MUI/ML, 5.35 MUI/ML, 6.02 MUI/ML. ON (B)(6) 2020: 5.13 MUI/ML. THE EXPECTED RANGE FOR THIS QC SAMPLE LEVEL 1 WAS 4.23 (3.51 - 4.949) RILIBÄK RANGE (17% DEVIATION). IT IS REPORTED THAT CALIBRATIONS PERFORMED ON (B)(6) 2020 AND ON (B)(6) 2020 WERE VALID. A BIOMÉRIEUX INTERNAL INVESTIGATION HAS BEEN INITIATED. NOTE: REFERENCE 30405 IS NOT REGISTERED IN THE UNITED STATES. THE U.S SIMILAR DEVICE IS PRODUCT REFERENCE 30405-01 (K141133).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1377463 VIDAS HCG VIDAS® HCG JLW BIOMERIEUX SA 1008107910

Patients

Seq Age Sex Outcome Treatment
1